|
培哚普利和氯沙坦治疗心肌梗死抑制心肌重构的前瞻性随机对比研究 |
|
2 Ferrari R, Chiariello M, Nicolosi GL, et al. Effects of Angiotensin-Converting Enzyme Inhibition With Perindopril on Left Ventricular Remodeling and Clinical Outcome: Results of the Randomized Perindopril and Remodeling in Elderly With Acute Myocardial Infarction (PREAMI) Study[J]. Arch Intern Med, 2006; 166 (3): 659~ 666
3 Pfeffer MA, McMurray JV, Velazquez EJ, et al. Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both[J]. N Engl J Med, 2003; 349: 1893~ 1906
4 Picciotto G, Sargiotto A, Petrarulo M, et al. Reliability of Captopril Renography in Patients Under Chronic Therapy with Angiotensin II (AT1) Receptor Antagonists[J]. J Nucl Med, 2003; 44: 1574~1581
5 Palmieri V, Dahlof B, DeQuattro V, et al. Reliability of echocardiographic assessment of left ventricular structure and function. J Am Coll Cardiol, 1999; 34: 1625~1632
6 Bolterman RJ, Manriquez MC, Ruiz MCO, et al. Effects of Captopril on the Renin Angiotensin System, Oxidative Stress, and Endothelin in Normal and Hypertensive Rats[J]. Hypertension, 2005; 46: 943~947
7 Solomon SD, Skali H, Anavekar NS,et al. Changes in Ventricular Size and Function in Patients Treated With Valsartan, Captopril, or Both After Myocardial Infarction [J]. Circulation, 2005; 111: 3411~3419
8 Diep QN, Mabrouk MEl, Yue P, et al. Effect of AT1 receptor blockade on cardiac apoptosis in angiotensin II-induced hypertension[J]. Am J Physiol Heart Circ Physiol, 2002; 282: H1635~H1641
9 Kaur K, Sharma AK, Singal PK. Significance of changes in TNF-α and IL-10 levels in the progression of heart failure subsequent to myocardial infarction[J]. Am J Physiol Heart Circ Physiol, 2006; 291: H106~H113
10 Devereux RB, Wachtell K, Gerdts E, et al. Prognostic Significance of Left Ventricular Mass Change During Treatment of Hypertension[J]. JAMA,2004; 292(19): 2350~2356
11 Zhuo J上一页 [1] [2] [3] [4] [5] [6] 下一页 上一个医学论文: 大剂量沐舒坦联合PEEP机械通气治疗ARDS 多例疗效观察 下一个医学论文: 罗哌卡因误注血管引起毒性反应1例
|
|
|